Shop

The amount of painkillers dispensed in the U.S. nearly quadrupled from 1999-2010 even though the amount of pain Americans have reported has not changed, resulting in what the Centers for Disease Control and prevention calls an epidemic which takes over twenty thousand lives each year. This was an impetus for Reporter Dina Gusovsky to investigate a publicly traded specialty pharmaceutical company called Insys Therapeutics, which is accused of contributing to these grim statistics. It's main revenue generating drug is a highly addictive opiate one hundred times more powerful that morphine, which the FDA says should only be used for late stage cancer pain; however, the company is now being investigated in at least six states for pushing the drug far beyond cancer patients, engaging in kickback schemes, off-label marketing, and other illegal business practices all in attempt to grow profits. Two days after our report first aired, which included exclusive interviews with whistleblowers and investigators, the company's CEO resigned. http://video.cnbc.com/gallery/?video=3000444339&play=1 http://video.cnbc.com/gallery/?video=3000445892&play=1 https://www.youtube.com/watch?v=m9Uy3eDqzUc https://www.youtube.com/watch?v=JP28vnux3yI https://www.youtube.com/watch?v=MXFetMnNJSk